Position in MRK
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$7,595,378
+$238,442 QoQ
Shares Held
59,108
-3.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.34%
of 13F equity value
Holder Rank
#849
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XML Financial, LLC holds $41,755,485 across 10 Drug Manufacturers - General names. MRK ranks #2 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
60,680 | $15,410,899 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
59,108 | $7,595,378 | |
| 3 | AMGN |
Amgen Inc
|
18,659 | $6,756,797 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
46,441 | $2,675,930 | |
| 5 | ABBV |
AbbVie Inc.
|
9,996 | $2,515,393 | |
| 6 | PFE |
Pfizer Inc
|
99,422 | $2,394,081 | |
| 7 | LLY |
ELI LILLY & Co
|
1,921 | $2,304,105 | |
| 8 | NVS |
Novartis AG
|
5,376 | $842,526 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,595,378 | 59,108 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $7,356,936 | 61,160 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $6,629,380 | 62,981 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $5,876,358 | 70,015 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $5,723,742 | 72,306 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $6,111,758 | 68,090 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $6,772,598 | 68,080 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $7,105,903 | 62,574 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $7,906,363 | 63,864 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $8,764,778 | 66,425 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $8,124,933 | 74,527 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,466,448 | 72,525 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $8,300,464 | 71,934 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $7,733,595 | 72,691 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $8,142,065 | 73,385 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,351,177 | 73,748 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $1,372,382 | 15,053 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $5,892,995 | 71,822 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $5,534,557 | 72,215 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,403,413 | 71,940 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,091,346 | 14,033 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $1,069,932 | 13,879 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,145,444 | 14,003 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,043,677 | 12,582 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $986,808 | 12,761 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $917,816 | 11,929 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||